Shoulder implant under the microscope: 10-Year safety study launches
NCT ID NCT04003272
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 59 people who received a specific shoulder implant (Versa-Dial Reverse Ti Glenosphere) to see how safe and effective it is over up to 10 years. Participants have shoulder arthritis, fractures, or a failed previous replacement. Researchers track complications, revisions, and patient-reported outcomes like pain and function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 59 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2019
- Expected to finish
-
Sep 2035
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Consecutive series of subjects implanted with the Comprehensive Versa-Dial Reverse Titanium (Ti) Glenosphere in primary, fracture and revision total shoulder arthroplasty according to the approved indications. Inclusion/exclusion criteria are identical to the indications and contraindications in the IFU.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Biomet Comprehensive Reverse Shoulder products are indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The Comprehensive Reverse Shoulder is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. Glenoid components with Hydroxyapatite (HA) coating applied over the porous coating are indicated only for uncemented biological fixation applications. The Glenoid Baseplate components are intended for cementless application with the addition of screw fixation. Interlok™ finish humeral stems are intended for cemented use and the MacroBond™ coated humeral stems are intended for press-fit or cemented applications. Humeral components with porous coated surface coating are indicated for either cemented or uncemented biological fixation applications. \*\*\* For the specific components, Titanium (Ti) Glenospheres are intended for patients with Cobalt Alloy material sensitivity. Exclusion Criteria: * Absolute contraindications include infection, sepsis, and osteomyelitis. Relative contraindications include: 1. Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions. 2. Osteoporosis. 3. Metabolic disorders which may impair bone formation. 4. Osteomalacia. 5. Distant foci of infections which may spread to the implant site. 6. Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram. 7. Patient is a prisoner. 8. Current alcohol or drug abuser. 9. If female, patient is known to be pregnant or breastfeeding. 10. Patient has a psychiatric illness or cognitive deficit that will not allow from proper informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Shoulder arthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Norton Orthopaedic and Sports Medicine
Louisville, Kentucky, 40241, United States
-
University of Buffalo
Buffalo, New York, 14215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 13-Minute eye exercise routine ease screen strain?
- Can targeted electroacupuncture and cupping beat standard needle therapy for shoulder pain?
- Could hidden nerve pain explain some shoulder pain cases?
- Why do some shoulder injections work better? a study looks for clues in pain type
- Can a new surgical classification predict better shoulder tendon healing?
- Could treating the neck ease shoulder pain?